Showing results (431-440 of 505) with videos related to
Sort By:
Pageof 51
Journal of Immunology (Baltimore, Md. : 1950)|December 31, 2010
A virus-like particle-based anti-nerve growth factor vaccine reduces inflammatory hyperalgesia: potential long-term therapy for chronic painTill A Röhn, William T Ralvenius, Jolly Paul, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 21, 2006
Cutting edge: identification of E-cadherin as a ligand for the murine killer cell lectin-like receptor G1Carsten Gründemann, Monika Bauer, Oliver Schweier, et al.Frontiers in Immunology|February 7, 2022
TLR7 Signaling Shapes and Maintains Antibody Diversity Upon Virus-Like Particle ImmunizationXinyue Chang, Pascal Krenger, Caroline C Krueger, et al.Immunity|March 1, 2011
Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center responseBaidong Hou, Philippe Saudan, Gary Ott, et al.Annals of the Rheumatic Diseases|March 14, 2019
Active immunisation targeting nerve growth factor attenuates chronic pain behaviour in murine osteoarthritisIsabell S von Loga, Aadil El-Turabi, Luke Jostins, et al.Scientific Reports|June 21, 2017
Nanoassembly routes stimulate conflicting antibody quantity and quality for transmission-blocking malaria vaccinesDarren B Leneghan, Kazutoyo Miura, Iona J Taylor, et al.Vaccines|August 29, 2024
Green Routes: Exploring Protein-Based Virus-like Nanoparticle Transport and Immune Activation in Nicotiana benthamiana for Biotechnological ApplicationsRomano Josi, Alessandro Pardini, Alexander Haindrich, et al.The Journal of Experimental Medicine|December 8, 1998
Vav regulates peptide-specific apoptosis in thymocytesY Y Kong, K D Fischer, M F Bachmann, et al.The Journal of Allergy and Clinical Immunology|February 7, 2013
The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthmaKai-Michael Beeh, Frank Kanniess, Frank Wagner, et al.Vaccine|August 7, 2002
A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responsesAndrea Jegerlehner, Alain Tissot, Franziska Lechner, et al.Pageof 51